RUNX2 and pulmonary arterial hypertension: It has been documented that miR-204 may act through RUNX2 to inhibit osteogenesis in mesenchymal progenitor cells [59], and expression of miR-204 has been widely recognized has a key factor in vascular remodeling in pulmonary arterial hypertension [60].